Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 364

1.

Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: an integrated evidence review and analysis of a large older adult hypertensive cohort.

Peters R, Anstey KJ, Booth A, Beckett N, Warwick J, Antikainen R, Rockwood K, Peters J, Bulpitt CJ.

Eur Heart J. 2018 Sep 1;39(33):3135-3143. doi: 10.1093/eurheartj/ehy418.

PMID:
30052878
2.

Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.

Antikainen RL, Peters R, Beckett NS, Fagard RH, Wang JG, Rajkumar C, Bulpitt CJ.

J Hypertens. 2016 Nov;34(11):2280-6. doi: 10.1097/HJH.0000000000001073.

PMID:
27552643
3.

Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly Trial.

Bulpitt CJ, Webb R, Beckett N, Peters R, Cheek E, Anderson C, Antikainen R, Staessen JA, Rajkumar C.

Blood Press. 2017 Apr;26(2):109-114. doi: 10.1080/08037051.2016.1219222. Epub 2016 Aug 22.

PMID:
27546817
4.

An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects.

Benetos A, Bulpitt CJ, Petrovic M, Ungar A, Agabiti Rosei E, Cherubini A, Redon J, Grodzicki T, Dominiczak A, Strandberg T, Mancia G.

Hypertension. 2016 May;67(5):820-5. doi: 10.1161/HYPERTENSIONAHA.115.07020. Epub 2016 Mar 14. Review. No abstract available.

PMID:
26975708
5.

Arterial compliance may be reduced by ingestion of red wine.

Fantin F, Bulpitt CJ, Zamboni M, Cheek E, Rajkumar C.

J Hum Hypertens. 2016 Jan;30(1):68-72. doi: 10.1038/jhh.2015.19. Epub 2015 Mar 19.

PMID:
25787780
6.

Response to HYVET ambulatory blood pressure substudy.

Bulpitt CJ, Beckett N, Peters R, Staessen JA.

Hypertension. 2013 May;61(5):e43. No abstract available.

PMID:
23724417
7.

Prevalence and covariates of electrocardiographic left ventricular hypertrophy in the Hypertension in the Very Elderly Trial.

Antikainen RL, Beckett N, Peters R, Fagard R, Rajkumar C, Wang J, Stoyanovsky V, Barrowdale D, Bulpitt CJ; HYVET Study Group.

J Hypertens. 2013 Jun;31(6):1224-32. doi: 10.1097/HJH.0b013e32836040a4.

PMID:
23588194
8.

Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project.

Bulpitt CJ, Beckett N, Peters R, Staessen JA, Wang JG, Comsa M, Fagard RH, Dumitrascu D, Gergova V, Antikainen RL, Cheek E, Rajkumar C.

Hypertension. 2013 Jan;61(1):89-94. doi: 10.1161/HYPERTENSIONAHA.112.191791. Epub 2012 Nov 19.

PMID:
23172934
9.

Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).

Bulpitt CJ, Beckett NS, Peters R, Leonetti G, Gergova V, Fagard R, Burch LA, Banya W, Fletcher AE.

J Hum Hypertens. 2012 Mar;26(3):157-63. doi: 10.1038/jhh.2011.10. Epub 2011 Mar 10.

PMID:
21390056
10.

Self management and patient understanding of diabetes in the older person.

Hewitt J, Smeeth L, Chaturvedi N, Bulpitt CJ, Fletcher AE.

Diabet Med. 2011 Jan;28(1):117-22. doi: 10.1111/j.1464-5491.2010.03142.x.

11.

CKD and hospitalization in the elderly: a community-based cohort study in the United Kingdom.

Nitsch D, Nonyane BA, Smeeth L, Bulpitt CJ, Roderick PJ, Fletcher A.

Am J Kidney Dis. 2011 May;57(5):664-72. doi: 10.1053/j.ajkd.2010.09.026. Epub 2010 Dec 13.

12.

Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.

Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, James MA, Knight J, Markus HS, Mistri AK, Poulter NR; COSSACS Investigators.

Lancet Neurol. 2010 Aug;9(8):767-75. doi: 10.1016/S1474-4422(10)70163-0.

PMID:
20621562
13.

Associations between cardiac target organ damage and microvascular dysfunction: the role of blood pressure.

Strain WD, Chaturvedi N, Hughes A, Nihoyannopoulos P, Bulpitt CJ, Rajkumar C, Shore AC.

J Hypertens. 2010 May;28(5):952-8. doi: 10.1097/HJH.0b013e328336ad6c.

PMID:
20216092
14.

Mortality according to a prior assessment of biological age.

Bulpitt CJ, Antikainen RL, Markowe HL, Shipley MJ.

Curr Aging Sci. 2009 Dec;2(3):193-9.

PMID:
20021413
15.

Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial.

Peters R, Poulter R, Beckett N, Forette F, Fagard R, Potter J, Swift C, Anderson C, Fletcher A, Bulpitt CJ.

J Hypertens. 2009 Oct;27(10):2055-62. doi: 10.1097/HJH.0b013e32832f4f02.

PMID:
19696686
16.

Irbesartan improves arterial compliance more than lisinopril.

Ali K, Rajkumar C, Fantin F, Schiff R, Bulpitt CJ.

Vasc Health Risk Manag. 2009;5(4):587-92. Epub 2009 Jul 14.

17.

Survival of community-dwelling older people: the effect of cognitive impairment and social engagement.

Sampson EL, Bulpitt CJ, Fletcher AE.

J Am Geriatr Soc. 2009 Jun;57(6):985-91.

PMID:
19507292
18.

CKD and mortality risk in older people: a community-based population study in the United Kingdom.

Roderick PJ, Atkins RJ, Smeeth L, Mylne A, Nitsch DD, Hubbard RB, Bulpitt CJ, Fletcher AE.

Am J Kidney Dis. 2009 Jun;53(6):950-60. doi: 10.1053/j.ajkd.2008.12.036. Epub 2009 Apr 25.

PMID:
19394727
19.

The prevalence of Type 2 diabetes and its associated health problems in a community-dwelling elderly population.

Hewitt J, Smeeth L, Bulpitt CJ, Fletcher AE.

Diabet Med. 2009 Apr;26(4):370-6. doi: 10.1111/j.1464-5491.2009.02687.x.

PMID:
19388966
20.

Baseline characteristics of participants in the Hypertension in the Very Elderly Trial (HYVET).

Bulpitt CJ, Beckett NS, Peters R, Banya W, Liu L, Wang JG, Stoyanovsky V, Dumitrascu D, Nikitin Y, Staessen JA, Burch L, Fletcher AE.

Blood Press. 2009;18(1-2):17-22. doi: 10.1080/08037050902836779.

PMID:
19353407

Supplemental Content

Loading ...
Support Center